Literature DB >> 17418805

Identification and characterization of the novel human prostate cancer-specific PC-1 gene promoter.

Jian Wang1, Hui Zhang, Rui-Xia Liang, Bo Pang, Qing-Guo Shi, Pei-Tang Huang, Cui-Fen Huang, Jian-Guang Zhou.   

Abstract

Human prostate and colon gene-1 (PC-1, also known as PrLZ) is an androgen-regulated, prostate tissue and prostate cancer cells specifically expressed novel gene. The increased expression of PC-1 gene appears to promote prostate cancer cells androgen-dependent (AD) and androgen-independent (AI) growth. To clone and investigate the expression and regulation elements of PC-1 gene may provide insight into the function of PC-1 and develop a new promoter that targets therapeutic genes to the AD and AI prostate cancer cells. The goal of the present study is cloning and characterization of the PC-1 promoter. A series of luciferase constructs that contain various fragments of the PC-1 5'-genomic region were transfected into human prostate cancer cells for promoter transactivation analysis. 5' deletion analysis identified the -1579 bp promoter region was required for the maximal proximal promoter activity; two transcriptional suppression and a positive regulatory region were identified; -4939 bp promoter fragment of the PC-1 gene retained the characteristic of prostate cancer-specific expression and exhibited higher transcription activity than PSA-6 kb promoter in the medium supplemented with steroid-depleted FBS. An androgen response element (ARE) was located in between -345 and -359 bp of the PC-1 5'-untranslated region relative to the translation initiation site. Thus, our studies not only provide molecular basis of PC-1 transcription regulation, but also define a new regulatory sequence that may be used to restrict expression of therapeutic genes to prostate cancer in the prostate cancer gene therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418805     DOI: 10.1016/j.bbrc.2007.02.153

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.

Authors:  Yoshiki Mukudai; Seiji Kondo; Atsushi Fujita; Yasuto Yoshihama; Tatsuo Shirota; Satoru Shintani
Journal:  Cell Oncol (Dordr)       Date:  2013-03-26       Impact factor: 6.730

2.  Expression of rod-derived cone viability factor: dual role of CRX in regulating promoter activity and cell-type specificity.

Authors:  Sophie Lambard; Sacha Reichman; Cynthia Berlinicke; Marie-Laure Niepon; Olivier Goureau; José-Alain Sahel; Thierry Léveillard; Donald J Zack
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

3.  Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.

Authors:  Lei Li; Hongjun Xie; Liang Liang; Ye Gao; Dong Zhang; Leiya Fang; Soo Ok Lee; Jie Luo; Xingfa Chen; Xinyang Wang; Luke S Chang; Shuyuan Yeh; Yuzhuo Wang; Dalin He; Chawnshang Chang
Journal:  Carcinogenesis       Date:  2012-10-26       Impact factor: 4.944

4.  Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.

Authors:  Tom Moritz; Simone Venz; Heike Junker; Sarah Kreuz; Reinhard Walther; Uwe Zimmermann
Journal:  Tumour Biol       Date:  2016-02-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.